BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21622209)

  • 21. Bortezomib induces apoptosis by interacting with JAK/STAT pathway in K562 leukemic cells.
    Selvi N; Kaymaz BT; Gündüz C; Aktan C; Kiper HD; Sahin F; Cömert M; Selvi AF; Kosova B; Saydam G
    Tumour Biol; 2014 Aug; 35(8):7861-70. PubMed ID: 24824872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease.
    Matsui F; Meldrum KK
    J Surg Res; 2012 Nov; 178(1):339-45. PubMed ID: 22883438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for liver complications after the Fontan procedure.
    Hilscher MB; Johnson JN; Cetta F; Driscoll DJ; Poterucha JJ; Sanchez W; Connolly HM; Kamath PS
    Congenit Heart Dis; 2017 Mar; 12(2):124-132. PubMed ID: 28140526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β/Smad and JAK/STAT pathways are involved in the anti-fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis.
    Xu S; Mao Y; Wu J; Feng J; Li J; Wu L; Yu Q; Zhou Y; Zhang J; Chen J; Ji J; Chen K; Wang F; Dai W; Fan X; Guo C
    J Cell Mol Med; 2020 May; 24(9):5224-5237. PubMed ID: 32233073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines, STATs and liver disease.
    Gao B
    Cell Mol Immunol; 2005 Apr; 2(2):92-100. PubMed ID: 16191414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
    Wang X; Liao X; Yu T; Gong Y; Zhang L; Huang J; Yang C; Han C; Yu L; Zhu G; Qin W; Liu Z; Zhou X; Liu J; Han Q; Peng T
    Int J Oncol; 2019 Oct; 55(4):805-822. PubMed ID: 31485610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia inhibitory factor regulates differentiation of trophoblastlike BeWo cells through the activation of JAK/STAT and MAPK3/1 MAP kinase-signaling pathways.
    Leduc K; Bourassa V; Asselin E; Leclerc P; Lafond J; Reyes-Moreno C
    Biol Reprod; 2012 Feb; 86(2):54. PubMed ID: 22053093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-25 improves IgA levels during parenteral nutrition through the JAK-STAT pathway.
    Heneghan AF; Pierre JF; Kudsk KA
    Ann Surg; 2013 Dec; 258(6):1065-71. PubMed ID: 23160152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.
    Gutiérrez-Hoya A; Soto-Cruz I
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel type-1 cytokine receptor from fish involved in the Janus kinase/signal transducers and activators of transcription (Jak/STAT) signal pathway.
    Santos MD; Yasuike M; Kondo H; Hirono I; Aoki T
    Mol Immunol; 2007 Jul; 44(13):3355-63. PubMed ID: 17383728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver.
    Gao B; Wang H; Lafdil F; Feng D
    J Hepatol; 2012 Aug; 57(2):430-41. PubMed ID: 22504331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.
    Cokic VP; Bhattacharya B; Beleslin-Cokic BB; Noguchi CT; Puri RK; Schechter AN
    J Transl Med; 2012 Jun; 10():116. PubMed ID: 22676255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging therapies of hepatitis B and C.
    Chen RY; Desmond PV; Locarnini SA
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of JAK/STAT signaling in neuroepithelial stem cell maintenance and proliferation in the Drosophila optic lobe.
    Wang W; Li Y; Zhou L; Yue H; Luo H
    Biochem Biophys Res Commun; 2011 Jul; 410(4):714-20. PubMed ID: 21651897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
    Lokau J; Garbers C
    Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the JAK-STAT pathway in myocardial injury.
    Barry SP; Townsend PA; Latchman DS; Stephanou A
    Trends Mol Med; 2007 Feb; 13(2):82-9. PubMed ID: 17194625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
    Ferrajoli A; Faderl S; Ravandi F; Estrov Z
    Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
    Martínez-Chantar ML; Vázquez-Chantada M; Ariz U; Martínez N; Varela M; Luka Z; Capdevila A; Rodríguez J; Aransay AM; Matthiesen R; Yang H; Calvisi DF; Esteller M; Fraga M; Lu SC; Wagner C; Mato JM
    Hepatology; 2008 Apr; 47(4):1191-9. PubMed ID: 18318442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.